Did you know? Your OTC medicines are eligible for cross-border sales to China — reaching millions of new customers.
We stay closely connected with Chinese regulatory authorities and stay ahead of the latest cross-border OTC policies — ensuring your brand remains fully compliant and competitive. We are China's leading cross-border OTC operations expert — and we're ready to help you succeed.
Proven track record
of 15 Years
Exclusive Dual
Qualifications for Cross-
Border OTC
Professional
Operations Team
step by step in China?
Low-Cost Market Entry
Brand Awareness Building
Brand Scale-Up
China Entry Model
Functional Claims
Operational Strategy
Overseas Direct Shipping, authorized to NYSO self-operated store, fully managed service
With NYSO's warehouses, enter Chinese market cost-effectively and introduce new sku with ease
Sold in NYSO's top-ranked online stores, drive brand awareness through high organic traffic
Bonded delivery & Overseas direct shipping, authorize NYSO to open flagship stores on CBEC channels
Help brand build consumer mindshare, strengthen brand equity, and develop loyalty programs
Engage users efficiently, strengthen user stickiness, and drive repeat purchases
Wholesale to distributors to expand sales channels, help brand to do general trade registration
Reach more consumers, boost brand sales efficiently, and create blockbuster products
Unlock brand value and social value, boost e-commerce promotion, amplify brand voice, and scale up operations
Exclusive Dual Qulifications for Cross-Border OTC Warehousing, Logistics and Sales
Well-Established Logistics and Warehousing System, Legitimate to Sell Overseas OTC in Mainland China, Hongkong, and Japan
A professional Team of Licensed Pharmacists and an Operations Team with Over 10 Years of Experience
Beijing Daxing Zone
20000+ orders daily
warehouse area 3000m²
Postive List
WMS+ERP+OMS+DPS
10+ years team experience
2023-12
In December 2023, NYSO was officially granted qualification to operate a cross-border OTC bonded warehouse in the Beijing Daxing Bonded Zone.2024-05
In May 2024, NYSO was granted a cross-border OTC trading pilot license in the Beijing Daxing Bonded Zone, making Yaoxin Warehouse the only facility authorized to handle storage, logistics, and sales for cross-border OTC.2025-06
In June 2025, NYSO was certified under GB/T 42061–2022 / ISO 13485:2016 standards for its medical device quality management system.
other regulatory restrictions, overseas direct shipping is a good alternative.
Kawasaki warehouse in Japan
Establish：2016 Size：2500㎡ Warehouse functions：OTC storage; overseas direct mail System：WMS+ERP+OMS+DPS Team experience：8 years+ Daily processing volume：10000+
Kowloon warehouse in HK SAR
Establish：2010 Size：1000㎡ Warehouse functions：OTC storage; overseas direct mail System：WMS+ERP+OMS+DPS Team experience：10 years+ Daily processing volume：10000+
・l Ikeda Mohando Co., Ltd. was founded in Toyama Prefecture, Japan in 1909 and has a history of more than 100 years. The anti-mosquito bite medicine under the brand "MUHI" has a high reputation in Japan, and having the highest market share in Hong Kong, Macau, Malaysia, Singapore and other countries and regions.
・l NYSO is the exclusive agent for MUHI in China's cross-border e-commerce market. Since May 2024, the brand has fulfilled delivery across all sales channels in China through an optimized logistics strategy. The store consistently ranks among the top in the international pharmaceutical category.
・Cooper Consumer Health, headquartered in Paris, is a leading OTC drug manufacturer and distributor in Europe, with over a century of brand history. The company has grown to become Europe's largest self-care provider, offering market-leading brands in calming, sleeping aids, and skincare.
・In 2024 July, Cooper Consumer Health successfully acquired Pfizer's OTC business, further strengthening its position as a leading healthcare platform in Europe. NYSO and Cooper Consumer Health has established an exclusive agency partnership.
・STADA is a leading OTC company in Europe, ranking fourth in 2023 with sales revenue of €1,632 million. Its consumer health portfolio spans Cough & Cold, Dermatology, Pain Relief, and more, with trusted brands like Grippostad, Nizoral, and Zoflora.
・STADA expands its product portfolio through brand optimization and strategic acquisitions, revitalizing heritage brands with dormant equity to unlock market potential. Committed to providing high-quality health products, STADA continues to grow sustainably, serving consumers worldwide.
・Laboratorios Viñas is a family-owned pharmaceutical company founded in Barcelona in 1911 and has become the nationwide popular brand in Spain.
・Laboratorios Viñas researches, develops, manufactures and markets its drugs and pharmaceutical products in a wide range of therapeutic areas, especially dermatology, gynaecology, paediatrics and general medicine.
・Its OTC minoxidil spray has gained significant consumer recognition in the Spanish pharmaceutical market.
・Qualiphar was established in 1937. As a Belgian family-run company, Qualiphar specialises in the research and development, manufacturing and marketing of OTC medications, food supplements, cosmetics and other healthcare products.
・Qualiphar relies on a long pharmaceutical history and a first-class R&D team to provide specialized manufacturing production services in more than 60 countries. Qualiphar is a proud partner of leading pharmaceutical companies including P&G, Viatris, STADA, etc.
Our Strategic Partners
Our goal is to provide brand owners with one-stop solutions to explore the Chinese market,
support brand growth, and bring outstanding international products to Chinese consumers.
